Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Analgesics Sector?

The size of the analgesics market has been on a consistent upward trajectory in the past few years. The market is anticipated to expand from $110.47 billion in 2024 to $113.1 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 2.4%. The growth during the historical period can be linked to the influence of alternative therapies, findings from safety and efficacy studies, the prevalence of pain, marketing strategies, and economic conditions.

The market for analgesics is forecasted to experience consistent expansion in the upcoming years. Its value is estimated to reach “$127.81 billion in 2029, growing at a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this expected growth in the forecast period include alternatives for pain management, competitive market factors, increased awareness of consumer health, demographic changes, and a rise in chronic diseases. Key trends expected during this period encompass personalized healthcare, non-opioid substitutes, the use of CBD and other cannabinoids, targeted pain management techniques, and improved access and affordability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

What Forces Are Driving The Growth Of The Analgesics Market?

The increased incidence of chronic diseases is propelling the growth of the analgesics market. Painkillers, alternatively known as analgesic drugs, are employed to alleviate severe or chronic body pain stemming from various health issues. To illustrate, the World Health Organization, a Swiss health entity, reported in September 2022 that chronic diseases, often referred to as noncommunicable diseases (NCDs), evolve over a prolonged time due to a mix of genetic, physiological, behavioral, and environmental factors. NCDs are responsible for 41 million deaths annually, constituting 74% of global mortalities. Each year, 17 million people under 70 succumb to an NCD, and these premature fatalities account for 86% of deaths in less wealthy countries. Interestingly, 77% of NCD-related deaths transpire in low- and middle-income nations. Thus, the escalating incidence of chronic ailments is a major factor propelling the expansion of the analgesics market.

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Emerging Trends And Strategic Shifts Are Shaping The Analgesics Market?

The analgesics marketplace is witnessing a surge of investments aimed at promoting growth, with top-ranked analgesic pharmaceutical producers infusing capital into clinical-stage firms. Through this, they not only manage to secure a competitive footing but also reinforce their market dominance. One of the major benefits of these investments is that they enable businesses to broaden their global footprint and shed light on novel products’ research and development. A case in point is Concentric Analgesics, Inc., a clinical-stage biopharmaceutical corporation in the US, which confirmed the closure of a $20 million convertible note financing deal involving a mix of new and previous investors in January 2022. With the intention of kick-starting registration-enabling phase 3 investigations for Vocacapsaicin, the capital infusion would also be utilized to accelerate Phase 3 development activities for Vocacapsaicin, post-surgical pain lead therapeutic candidate of Concentric Analgesics. This financial closure holds immense significance for Concentric Analgesics by enabling the firm’s continuous stride towards pushing Vocacapsaicin into Phase 3 development, thereby marking a pivotal initial move towards underwriting the program in its entirety until the NDA submission.

Which Companies Currently Dominate The Competitive Landscape In The Analgesics Industry?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Geographic Regions Are Driving Demand In The Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model